questionsmedicales.fr
Disciplines et activités comportementales
Psychothérapie
Thérapie comportementale
Thérapie comportementale : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thérapie comportementale : Questions médicales les plus fréquentes",
"headline": "Thérapie comportementale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thérapie comportementale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-14",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Psychothérapie",
"url": "https://questionsmedicales.fr/mesh/D011613",
"about": {
"@type": "MedicalCondition",
"name": "Psychothérapie",
"code": {
"@type": "MedicalCode",
"code": "D011613",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie de maitrise de la colère",
"alternateName": "Anger Management Therapy",
"url": "https://questionsmedicales.fr/mesh/D000067449",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie de maitrise de la colère",
"code": {
"@type": "MedicalCode",
"code": "D000067449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.087"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Analyse comportementale appliquée",
"alternateName": "Applied Behavior Analysis",
"url": "https://questionsmedicales.fr/mesh/D000072357",
"about": {
"@type": "MedicalCondition",
"name": "Analyse comportementale appliquée",
"code": {
"@type": "MedicalCode",
"code": "D000072357",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.131"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie aversive",
"alternateName": "Aversive Therapy",
"url": "https://questionsmedicales.fr/mesh/D001348",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie aversive",
"code": {
"@type": "MedicalCode",
"code": "D001348",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.174"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie cognitive",
"alternateName": "Cognitive Behavioral Therapy",
"url": "https://questionsmedicales.fr/mesh/D015928",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie cognitive",
"code": {
"@type": "MedicalCode",
"code": "D015928",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie d'acceptation et d'engagement",
"alternateName": "Acceptance and Commitment Therapy",
"url": "https://questionsmedicales.fr/mesh/D064869",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie d'acceptation et d'engagement",
"code": {
"@type": "MedicalCode",
"code": "D064869",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Restructuration cognitive",
"alternateName": "Cognitive Restructuring",
"url": "https://questionsmedicales.fr/mesh/D000088686",
"about": {
"@type": "MedicalCondition",
"name": "Restructuration cognitive",
"code": {
"@type": "MedicalCode",
"code": "D000088686",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pleine conscience",
"alternateName": "Mindfulness",
"url": "https://questionsmedicales.fr/mesh/D064866",
"about": {
"@type": "MedicalCondition",
"name": "Pleine conscience",
"code": {
"@type": "MedicalCode",
"code": "D064866",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Remédiation cognitive",
"alternateName": "Cognitive Remediation",
"url": "https://questionsmedicales.fr/mesh/D000072466",
"about": {
"@type": "MedicalCondition",
"name": "Remédiation cognitive",
"code": {
"@type": "MedicalCode",
"code": "D000072466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.365"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Désensibilisation psychologique",
"alternateName": "Desensitization, Psychologic",
"url": "https://questionsmedicales.fr/mesh/D003887",
"about": {
"@type": "MedicalCondition",
"name": "Désensibilisation psychologique",
"code": {
"@type": "MedicalCode",
"code": "D003887",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Désensibilisation et reprogrammation par mouvements oculaires",
"alternateName": "Eye Movement Desensitization Reprocessing",
"url": "https://questionsmedicales.fr/mesh/D057169",
"about": {
"@type": "MedicalCondition",
"name": "Désensibilisation et reprogrammation par mouvements oculaires",
"code": {
"@type": "MedicalCode",
"code": "D057169",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.162"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie implosive",
"alternateName": "Implosive Therapy",
"url": "https://questionsmedicales.fr/mesh/D007171",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie implosive",
"code": {
"@type": "MedicalCode",
"code": "D007171",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.325"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par réalité virtuelle",
"alternateName": "Virtual Reality Exposure Therapy",
"url": "https://questionsmedicales.fr/mesh/D063367",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par réalité virtuelle",
"code": {
"@type": "MedicalCode",
"code": "D063367",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.662"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thérapie comportementale dialectique",
"alternateName": "Dialectical Behavior Therapy",
"url": "https://questionsmedicales.fr/mesh/D000077252",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale dialectique",
"code": {
"@type": "MedicalCode",
"code": "D000077252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.628"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par la relaxation",
"alternateName": "Relaxation Therapy",
"url": "https://questionsmedicales.fr/mesh/D012064",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par la relaxation",
"code": {
"@type": "MedicalCode",
"code": "D012064",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Méditation",
"alternateName": "Meditation",
"url": "https://questionsmedicales.fr/mesh/D019122",
"about": {
"@type": "MedicalCondition",
"name": "Méditation",
"code": {
"@type": "MedicalCode",
"code": "D019122",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.750.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chronothérapie sur les phases de sommeil",
"alternateName": "Sleep Phase Chronotherapy",
"url": "https://questionsmedicales.fr/mesh/D055865",
"about": {
"@type": "MedicalCondition",
"name": "Chronothérapie sur les phases de sommeil",
"code": {
"@type": "MedicalCode",
"code": "D055865",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale",
"alternateName": "Behavior Therapy",
"code": {
"@type": "MedicalCode",
"code": "D001521",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Daniel F Gros",
"url": "https://questionsmedicales.fr/author/Daniel%20F%20Gros",
"affiliation": {
"@type": "Organization",
"name": "Mental Health Service, Ralph H. Johnson VA Healthcare System, Charleston, South Carolina, USA."
}
},
{
"@type": "Person",
"name": "Tanja van der Zweerde",
"url": "https://questionsmedicales.fr/author/Tanja%20van%20der%20Zweerde",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands. Electronic address: t.vander.zweerde@vu.nl."
}
},
{
"@type": "Person",
"name": "Jaap Lancee",
"url": "https://questionsmedicales.fr/author/Jaap%20Lancee",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, University of Amsterdam, Nieuwe Achtergracht 129, Amsterdam 1018 WS, the Netherlands; PsyQ Amsterdam, Amsterdam, the Netherlands."
}
},
{
"@type": "Person",
"name": "Annemieke van Straten",
"url": "https://questionsmedicales.fr/author/Annemieke%20van%20Straten",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands."
}
},
{
"@type": "Person",
"name": "Shireen L Rizvi",
"url": "https://questionsmedicales.fr/author/Shireen%20L%20Rizvi",
"affiliation": {
"@type": "Organization",
"name": "Rutgers University. Electronic address: slrizvi@gsapp.rutgers.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Gaze tracker parameters have little association with visual field metrics of intrasession frontloaded SITA-Faster 24-2 visual field results.",
"datePublished": "2022-05-22",
"url": "https://questionsmedicales.fr/article/35598152",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/opo.13006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic accuracy of an iPad application for detection of visual field defects.",
"datePublished": "2022-09-05",
"url": "https://questionsmedicales.fr/article/36064770",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41433-022-02223-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rates of Visual Field Change in Eyes With Optic Disc Drusen.",
"datePublished": "2023-01-18",
"url": "https://questionsmedicales.fr/article/36728098",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/WNO.0000000000001801"
}
},
{
"@type": "ScholarlyArticle",
"name": "Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma.",
"datePublished": "2023-05-02",
"url": "https://questionsmedicales.fr/article/37142176",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajo.2023.04.017"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intereye comparison of visual field progression in eyes with open-angle glaucoma.",
"datePublished": "2023-03-18",
"url": "https://questionsmedicales.fr/article/36933119",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10384-023-00982-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines et activités comportementales",
"item": "https://questionsmedicales.fr/mesh/D004191"
},
{
"@type": "ListItem",
"position": 3,
"name": "Psychothérapie",
"item": "https://questionsmedicales.fr/mesh/D011613"
},
{
"@type": "ListItem",
"position": 4,
"name": "Thérapie comportementale",
"item": "https://questionsmedicales.fr/mesh/D001521"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thérapie comportementale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thérapie comportementale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thérapie comportementale",
"description": "Comment diagnostiquer un besoin de thérapie comportementale ?\nQuels tests sont utilisés pour le diagnostic ?\nQui peut poser un diagnostic pour cette thérapie ?\nQuels critères sont utilisés pour le diagnostic ?\nLa thérapie comportementale est-elle adaptée à tous ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thérapie comportementale",
"description": "Quels symptômes indiquent un besoin de thérapie comportementale ?\nComment les symptômes varient-ils selon les individus ?\nLes symptômes physiques sont-ils liés à la thérapie comportementale ?\nLes symptômes peuvent-ils s'aggraver sans traitement ?\nQuels sont les signes d'amélioration avec la thérapie ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thérapie comportementale",
"description": "Comment prévenir les troubles nécessitant une thérapie comportementale ?\nLes programmes scolaires peuvent-ils aider à la prévention ?\nQuels rôles jouent les parents dans la prévention ?\nLa prévention est-elle possible à l'âge adulte ?\nLes groupes de soutien peuvent-ils aider à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thérapie comportementale",
"description": "Quelles techniques sont utilisées en thérapie comportementale ?\nCombien de séances sont généralement nécessaires ?\nLa thérapie comportementale peut-elle être combinée avec d'autres traitements ?\nQuels sont les objectifs principaux de cette thérapie ?\nLa thérapie comportementale est-elle efficace pour les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thérapie comportementale",
"description": "Quelles complications peuvent survenir sans traitement ?\nLa thérapie comportementale peut-elle entraîner des effets secondaires ?\nQuels risques de rechute existent après la thérapie ?\nLes complications psychologiques peuvent-elles affecter la santé physique ?\nComment minimiser les complications après la thérapie ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thérapie comportementale",
"description": "Quels facteurs augmentent le risque de troubles comportementaux ?\nL'environnement familial influence-t-il les comportements ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe manque de soutien social est-il un facteur de risque ?\nLes événements de vie stressants augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un besoin de thérapie comportementale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel évalue les comportements problématiques et leur impact sur la vie quotidienne."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires et des entretiens cliniques sont souvent utilisés pour évaluer les comportements."
}
},
{
"@type": "Question",
"name": "Qui peut poser un diagnostic pour cette thérapie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un psychologue, un psychiatre ou un thérapeute qualifié peut poser ce diagnostic."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la fréquence, l'intensité et l'impact des comportements sur la vie."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale est-elle adaptée à tous ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est efficace pour de nombreux troubles, mais un diagnostic précis est essentiel."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de thérapie comportementale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des comportements compulsifs, des phobies ou des troubles d'anxiété peuvent indiquer ce besoin."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les individus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier en intensité et en type selon les expériences personnelles."
}
},
{
"@type": "Question",
"name": "Les symptômes physiques sont-ils liés à la thérapie comportementale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes physiques comme des palpitations peuvent accompagner des troubles psychologiques."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver sans traitement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les symptômes peuvent s'intensifier et affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'amélioration avec la thérapie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une réduction des comportements problématiques et une meilleure gestion des émotions sont des signes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles nécessitant une thérapie comportementale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation émotionnelle et le développement de compétences sociales dès le jeune âge."
}
},
{
"@type": "Question",
"name": "Les programmes scolaires peuvent-ils aider à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des programmes de sensibilisation et de gestion des émotions dans les écoles peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Quels rôles jouent les parents dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les parents peuvent enseigner des stratégies de gestion du stress et des comportements positifs à leurs enfants."
}
},
{
"@type": "Question",
"name": "La prévention est-elle possible à l'âge adulte ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques de gestion du stress et de résolution de problèmes peuvent prévenir l'apparition de troubles."
}
},
{
"@type": "Question",
"name": "Les groupes de soutien peuvent-ils aider à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les groupes de soutien offrent un espace pour partager des expériences et apprendre des stratégies de prévention."
}
},
{
"@type": "Question",
"name": "Quelles techniques sont utilisées en thérapie comportementale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme le conditionnement opérant, l'exposition et la restructuration cognitive sont courantes."
}
},
{
"@type": "Question",
"name": "Combien de séances sont généralement nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le nombre de séances varie, mais 10 à 20 séances sont souvent recommandées pour des résultats significatifs."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale peut-elle être combinée avec d'autres traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent combinée avec des médicaments ou d'autres formes de thérapie pour une efficacité accrue."
}
},
{
"@type": "Question",
"name": "Quels sont les objectifs principaux de cette thérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les objectifs incluent la modification des comportements inadaptés et l'amélioration des compétences d'adaptation."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale est-elle efficace pour les enfants ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent utilisée pour traiter des troubles chez les enfants, comme l'anxiété et les phobies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans traitement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans traitement, les troubles peuvent s'aggraver, entraînant des problèmes relationnels et professionnels."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale peut-elle entraîner des effets secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Généralement, elle n'a pas d'effets secondaires physiques, mais des émotions intenses peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels risques de rechute existent après la thérapie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des rechutes peuvent survenir si les compétences acquises ne sont pas pratiquées régulièrement."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques peuvent-elles affecter la santé physique ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles psychologiques non traités peuvent entraîner des problèmes de santé physique, comme des maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment minimiser les complications après la thérapie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pratique continue des compétences apprises et le soutien social aident à minimiser les complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de troubles comportementaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme le stress, l'hérédité et des événements traumatiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'environnement familial influence-t-il les comportements ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement familial instable ou conflictuel peut contribuer au développement de troubles."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de troubles mentaux dans la famille peuvent augmenter le risque de troubles comportementaux."
}
},
{
"@type": "Question",
"name": "Le manque de soutien social est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un manque de soutien social peut exacerber les troubles et rendre la gestion plus difficile."
}
},
{
"@type": "Question",
"name": "Les événements de vie stressants augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des événements comme un divorce ou la perte d'un emploi peuvent déclencher des troubles comportementaux."
}
}
]
}
]
}
To determine the usefulness of Humphrey Field Analyser (HFA) SITA-Faster 24-2 gaze tracker outputs on interpreting intra-visit visual field (VF) result pairs....
Analysis of 1380 right-left eye pairs and 1432 pairs of test 1-test 2 intrasession VF results of patients seen within a university-based glaucoma service was undertaken to understand gaze deviation di...
There was no association of test order (right-left, test 1-test 2) with eye movements. There was a significant, but weak correlation between eye movements and age (r = 0.16). Correlations of eye movem...
Eye movement parameters as currently reported by the HFA do not appear to be correlated with key sensitivity parameters when considering the repeatability of intrasession SITA-Faster 24-2 VF results. ...
Tablet-based perimetry could be used to test for glaucomatous visual field defects in settings without easy access to perimeters, although few studies have assessed diagnostic accuracy of tablet-based...
This was a prospective, cross-sectional study of patients undergoing their first Humphrey Field Analyser (HFA) visual field test at a glaucoma clinic in India. Participants underwent 24-2 SITA Standar...
203 eyes from 115 participants were included, with 82 eyes classified as moderate or worse glaucoma. iPad perimetry had an area under the receiver operating characteristic (AUROC) curve of 0.64 (95% C...
iPad perimetry using the visualFields Easy application had inadequate diagnostic accuracy to be used as a screening tool for glaucoma in this South Indian population....
Optic disc drusen (ODD) are calcified deposits in the prelaminar portion of the optic nerve head. Although often asymptomatic, these deposits can cause progressive visual field defects and vision loss...
This was a retrospective cohort study including 65 eyes of 43 patients with ODD from the Duke Ophthalmic Registry. All eyes had at least 12 months of follow-up and at least 3 reliable standard automat...
Subjects were followed for an average of 7.6 ± 5.3 years. The mean rate of SAP MD change was -0.23 ± 0.26 dB/year, ranging from -1.19 to 0.13 dB/year. Fifty-seven eyes (87.7%) had slow progression (sl...
Most eyes with ODD had slow rates of visual field loss over time. Age and baseline severity were significantly associated with faster rates of visual field loss....
To evaluate the association between baseline severity of visual field (VF) damage and the initial rates of VF progression with quality of life (QOL) outcomes over an extended follow-up in glaucoma....
Retrospective cohort study....
Both eyes of 167 glaucoma or suspected glaucoma patients were followed for 10.0±0.3 years. The National Eye Institute Visual Function Questionnaire (NEI-VFQ)-25 was performed at the end of the follow-...
All models demonstrated association of worse baseline severity of VF damage with worse subsequent NEI-VFQ-25 scores. Faster rates of decline in VF mean deviation of the better eye and the mean sensiti...
Baseline severity and initial rates of change of VF damage are associated with QOL outcomes over an extended follow-up. Assessment of longitudinal VF changes, especially in better eye, provides progno...
To investigate the intereye correlations between and differences in the rates of visual field (VF) progression in eyes with bilateral open-angle glaucoma....
Retrospective, longitudinal, observational study....
Patients with bilateral open-angle glaucoma with 8 or more reliable 30 - 2 standard automated perimetry tests over a period of more than 2 years were enrolled. The rate of change of the MD (MD slope) ...
One hundred eighty-eight eyes from 94 patients (56 women) were enrolled. A significant intereye correlation of the rates of visual field progression (P = .002) was found. The mean ± standard deviation...
A significant intereye correlation in the rate of VF progression was found in eyes with bilateral open-angle glaucoma. We showed the distributions and associated factors of intereye differences in VF ...
Timely treatment is essential in the management of glaucoma. However, subjective assessment of visual field (VF) progression is not recommended, because it can be unreliable. There are two types of ar...
A novel visual field screening program with a head-mounted perimeter 'imo' could detect glaucoma at all stages in a short time with high accuracy....
The present study aimed to examine the accuracy and availability of a novel glaucoma visual field screening program using a head-mounted visual perimeter 'imo.'...
Eyes of 76 non-glaucoma participants and 92 glaucoma patients were examined. All patients underwent visual field tests using the Humphrey Visual Field Analyzer (30-2 or 24-2 Swedish Interactive Thresh...
The sensitivity, specificity, positive predictive value, and negative predictive value of the visual field screening program were 76%-100%, 91%-100%, 86%-89%, and 79%-100%, respectively. The visual fi...
Visual field screening using a head-mounted perimeter 'imo' detected glaucoma at all stages in a short time with high accuracy....
COVID-19 underlines the importance of telemedical diagnostics. The smartphone-based campimetry (Sb-C) is a newly developed digital application allowing visual field testing using a head-mounted device...
Sb-C is a newly developed tool for functional ophthalmic diagnosis. This study aimed to examine the comparability of the Sb-C and Octopus 900 to ensure ophthalmological care in times of social distanc...
Total 93 eyes were included in the study. After an ophthalmological examination, the visual field was tested by the Octopus program G1 and by the smartphone-based campimeter. The Sb-C was performed us...
The group comprised 48 women and 45 men (mean age: 62.52±12.2 y) including 19 controls, 17 patients with ocular hypertension, 11 preperimetric glaucomas, and 46 perimetric glaucomas. The mean sensitiv...
With some technical adjustments, the Sb-C shows promise for screening glaucoma and monitoring disease progression remotely from an ophthalmologic clinic....
Individuals with homonymous visual field loss (HVFL) fail to perceive visual information that falls within the blind portions of their visual field. This places additional burden on memory to represen...
Contrast sensitivity (CS) is closely associated with vision-related quality of life in glaucoma patients. This cross-sectional study was performed to determine the relationship between CS and visual f...